UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002394
Receipt number R000002941
Scientific Title A multicenter study of new anticancer agent for patients with advanced hepatocellular carcinoma : efficacy and safety
Date of disclosure of the study information 2009/09/01
Last modified on 2013/09/02 08:57:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter study of new anticancer agent for patients with advanced hepatocellular carcinoma : efficacy and safety

Acronym

A multicenter study of new anticancer agent for patients with advanced hepatocellular carcinoma : efficacy and safety

Scientific Title

A multicenter study of new anticancer agent for patients with advanced hepatocellular carcinoma : efficacy and safety

Scientific Title:Acronym

A multicenter study of new anticancer agent for patients with advanced hepatocellular carcinoma : efficacy and safety

Region

Japan


Condition

Condition

Hapatocellular carcinoma

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To identify therapeutic efficacy and safety of new-anticancer agent for patients with advanced hepatocellular carcinoma, and investigate proper patient selection, protocol and prevention of adverse effect

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety of new anti-cancer agents : Incidence of adverse event

Key secondary outcomes

Efficacy of new anti-cancer agents : Overall survival, progression-free survival, time to disease progression, overall response rate


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Hepatocellular carcionoma confirmed by dynamic CT or dynamic MRI, or histologically confirmed hepatocellular carcinoma

2) Unresectable advanced hepatocellular carcinoma treated by new anticancer agent

3) Written informed consents

Key exclusion criteria

1) Contraindication of new anticancer agent
2) The investigator consider not suitable for the study

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shuichi Kaneko

Organization

Kanazawa University Hospital

Division name

Department of Gastrenterology

Zip code


Address

13-1 Takara-Machi, Kanazawa, Ishikawa

TEL

076-265-2233

Email



Public contact

Name of contact person

1st name
Middle name
Last name Tatsuya Yamashita

Organization

Kanazawa University Hospital

Division name

Department of Gastrenterology

Zip code


Address

13-1 Takara-machi, Kanazawa, Ishikawa

TEL

076-265-2861

Homepage URL


Email

ytatsuya@m-kanazawa.jp


Sponsor or person

Institute

Kanazawa University Hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

金沢大学附属病院(石川県)
愛媛大学附属病院(愛媛県)
鳥取大学附属病院(鳥取県)
千葉大学附属病院(千葉県)
山口大学附属病院(山口県)
大阪大学附属病院(大阪府)
杏林大学附属病院(東京都)
東北大学附属病院(宮城県)
昭和大学附属病院(東京都)
兵庫医科大学附属病院(兵庫県)
近畿大学附属病院(大阪府)
岐阜大学附属病院(岐阜県)
岡山大学附属病院(岡山県)
虎ノ門病院(東京都)
久留米大学附属病院(福岡県)


Other administrative information

Date of disclosure of the study information

2009 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 09 Month 01 Day

Date of IRB


Anticipated trial start date

2009 Year 10 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective study, non-random sampling


Management information

Registered date

2009 Year 08 Month 27 Day

Last modified on

2013 Year 09 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002941


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name